Seventh Valmet supplied tissue line successfully started up at Hengan's mill in China, with more to come

Valmet Oyj's trade press release on February 21, 2018 at 11:00 a.m. EET

Valmet and Hengan joined forces on January 15, 2018, to successfully start a Valmet Advantage DCT 200 tissue line at Hengan's mill in Weifang, China.

PM21 is the third of four Advantage DCT 200 lines recently ordered by Hengan. When the startup of PM22 takes place at the same mill in Weifang later this year, Hengan will have a total of eight Valmet supplied tissue production lines in operation. The other two Advantage DCT 200 machines were started in Wuhu, China, with excellent results in 2016. All three startups have been well coordinated and performed in record time, which creates a great outlook for the upcoming PM22 premiere.

The investments support Hengan's aim of strengthening their leading market position in China, while the well proven Advantage DCT Technology ensures a stable production of high-quality tissue, in this case mainly used for facial, toilet and towel grades.

Hengan is China's leading tissue producer, with a current tissue production exceeding one million tons per year. The high-performance Advantage DCT 200 trio counts for an annual capacity of least 180,000 tons of tissue products, soon to be 240,000 tons once all four production lines are started and optimized.

Valmet's and Hengan's teams in front of the newly started Advantage DCT 200 line and the first jumbo roll, in Weifang, China.

Technical information about the deliveries

Valmet's delivery comprises of four Advantage DCT 200 tissue production lines, featuring automation, stock preparation systems and the well-proven Advantage technology including OptiFlo headbox, Yankee, AirCap hood, WetDust dust system and SoftReel reel. The machines are 5.6 meters wide and operates at 2,000 m/min.

Information about Hengan

Hengan International Group Company Limited is an investment holding company mainly engaged in the trading of personal hygienic products. The company and its subsidiaries are principally engaged in the manufacturing, distribution and sale of personal hygiene products, including sanitary napkins, disposable diapers and tissue papers products, food and snacks products and others in the People's Republic of China, Hong Kong and certain overseas markets.

VALMET
Corporate Communications

For further information, please contact:
Svenerik Olsson, Director, Valmet China Tissue, +86 10 6566 2568-3137
Mikael K Olsson, Project Manager, Valmet Tissue Mills Business Unit, +46 54 17 10 55

Valmet is the leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. We aim to become the global champion in serving our customers.

Valmet's strong technology offering includes pulp mills, tissue, board and paper production lines, as well as power plants for bioenergy production. Our advanced services and automation solutions improve the reliability and performance of our customers' processes and enhance the effective utilization of raw materials and energy.

Valmet's net sales in 2017 were approximately EUR 3.2 billion. Our more than 12,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day. Valmet's head office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.

Seventh Valmet supplied tissue line successfully started up at Hengan's mill in China, with more to come

Local websites